Although IL-7R has been identified as a risk factor for hepatitis B virus (HBV)-related HCC in previous studies, some comprehensive studies have revealed its potential protective role in HCC cases beyond solely HBV-related instances (Kong et al., 2016; Yin et al., 2020; Zhuang et al., 2021). This evidence concerns the gene IL7R and hepatocellular carcinoma.